Quadratus Lumborum vs Erector Spinae Supplementary Blocks With Lumbar Plexus Blocks for Hip PAO

• Status: Recruiting
• Trial end date: 2022-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This study proposes to evaluate the efficacy of single shot erector spinae block (ESB) versus single shot quadratus lumborum block (QLB) when used in conjunction with continuous lumbar plexus block (LPB) for postoperative analgesia in children and adolescents undergoing unilateral hip surgical procedures. The aim of this study is to compare the efficacy of the QL vs. ESP blocks as supplements to the lumbar plexus block with respect to pain control outcomes after hip PAO surgery. Both blocks are safe and easy to perform. There is currently no comparative, prospective data concerning the use of these two blocks for hip surgery. The investigational hypothesis is that there will be no clinical difference in the amount of opioid consumed or the overall pain control offered by these two block options.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Boston Children's Hospital; Boston Children’s Hospital
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

1. ASA I - III status, undergoing unilateral periacetabular osteotomy for treating primary diagnosis of developmental acetabular dysplasia in symptomatic young patients.

2. Ages 15 - 30 years

Exclusion Criteria:

1. Patients undergoing procedures including revision PAO, bilateral PAO, conversion to total hip arthroplasty.

2. Patients whom for any reason did not received a lumbar plexus catheter as part of the baseline regional anesthesia plan

3. Patients with body mass index (BMI) > 35

4. Patients with known coagulopathies.

5. Patients with severe neurodevelopmental delays.

6. Patients with previous chronic pain syndromes.

7. Patients with a history of opioid treatment at any point in the 2 months prior to surgery.

8. Lack of parental consent and/or patient assent.